Research led by Rockefeller University in New York investigated alternate targets for monoclonal antibodies to combat SARS-CoV-2 infections.
Researchers in Japan have uncovered the mechanism for how the measles virus can cause subacute sclerosing panencephalitis, or SSPE, a rare but fatal neurological disorder that can occur several years after a measles infection.
Jan 27, 2023
0
156
A new COVID-19 vaccine based on a different platform than current vaccines on the market has been tested in humans for the first time by researchers at Radboud university medical center. Administration of this vaccine in ...
Jan 25, 2023
0
65
After three years of infections, lockdowns, and vaccinations, we know a lot about SARS-CoV-2, the virus that causes COVID-19—but we don't know everything. Like, why are some variants weaker than others? Why does the omicron ...
Jan 11, 2023
2
73
Messenger RNA vaccine technology, once an arcane area of research, became household terminology because of the COVID-19 pandemic, and now scientists are working on an mRNA flu vaccine strategy that, at least in this study, ...
A team of researchers at the University of Sydney working with a colleague from Shenzhen University School of Medicine has found that lab mice are more likely to survive a flu infection if they are fed grain-based foods rather ...
Northwestern Medicine scientists have discovered how herpes viruses hijack cellular transport processes to infiltrate the nervous system, as described in a study published in the Proceedings of the National Academy of Sciences.
14 hours ago
0
20
The HIV variant dominant in Indonesia was introduced from Thailand over multiple events. A Kobe University study traces where it came from and how it spread from there, offering possible insights into the development of treatments ...
21 hours ago
1
28
Tiny, dangerous, and easily transmitted hepatitis B virus (HBV) chronically affects about 296 million people and kills about 1 million every year. This stealthy virus invades the liver and remains largely asymptomatic until ...
May 8, 2024
0
27
Duke researchers have opened a new avenue in the attack against influenza viruses by creating a vaccine that encourages the immune system to target a portion of the virus surface that is less variable.
May 1, 2024
0
11
